259 related articles for article (PubMed ID: 34902834)
1. Case Report: Rhino-orbital Mucormycosis Related to COVID-19: A Case Series Exploring Risk Factors.
Aggarwal SK; Kaur U; Talda D; Pandey A; Jaiswal S; Kanakan A; Singh A; Chakrabarti SS
Am J Trop Med Hyg; 2021 Dec; 106(2):566-570. PubMed ID: 34902834
[TBL] [Abstract][Full Text] [Related]
2. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report.
Veisi A; Bagheri A; Eshaghi M; Rikhtehgar MH; Rezaei Kanavi M; Farjad R
Eur J Ophthalmol; 2022 Jul; 32(4):NP11-NP16. PubMed ID: 33843287
[TBL] [Abstract][Full Text] [Related]
3. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India.
Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA
Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435
[TBL] [Abstract][Full Text] [Related]
4. Analysis of COVID-19-associated rhino-orbital-cerebral mucormycosis patients in a tertiary care center in Northern India.
Yadav H; Sen S; Nath T; Mazumdar S; Jain A; Verma P; Gupta P
Indian J Ophthalmol; 2022 Jun; 70(6):2163-2168. PubMed ID: 35648004
[TBL] [Abstract][Full Text] [Related]
5. COVID-19-associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic's second wave in India.
Aranjani JM; Manuel A; Abdul Razack HI; Mathew ST
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009921. PubMed ID: 34793455
[TBL] [Abstract][Full Text] [Related]
6. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
[TBL] [Abstract][Full Text] [Related]
7. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus.
Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N
J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273
[TBL] [Abstract][Full Text] [Related]
8. Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center.
Singh SP; Rana J; Singh VK; Singh R; Sachan R; Singh S; Jain S
Rom J Ophthalmol; 2021; 65(4):339-353. PubMed ID: 35087975
[No Abstract] [Full Text] [Related]
9. Mucormycosis in patients with COVID-19: A cross-sectional descriptive multicentre study from Iran.
Pakdel F; Ahmadikia K; Salehi M; Tabari A; Jafari R; Mehrparvar G; Rezaie Y; Rajaeih S; Alijani N; Barac A; Abdollahi A; Khodavaisy S
Mycoses; 2021 Oct; 64(10):1238-1252. PubMed ID: 34096653
[TBL] [Abstract][Full Text] [Related]
10. Coronavirus disease-associated mucormycosis (CAM): A case control study during the outbreak in India.
Wasiq M; K R; Gn A
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443518
[TBL] [Abstract][Full Text] [Related]
11. Outcome of COVID-19-Associated Rhino-Orbital Mucormycosis.
Arora R; Goel R; Meher R
JAMA Ophthalmol; 2022 May; 140(5):548. PubMed ID: 35389467
[No Abstract] [Full Text] [Related]
12. Outcome of COVID-19-Associated Rhino-Orbital Mucormycosis-Reply.
Date PS; Choksi T; Ingole AB
JAMA Ophthalmol; 2022 May; 140(5):548-549. PubMed ID: 35389457
[No Abstract] [Full Text] [Related]
13. Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations.
Bayram N; Ozsaygılı C; Sav H; Tekin Y; Gundogan M; Pangal E; Cicek A; Özcan İ
Jpn J Ophthalmol; 2021 Jul; 65(4):515-525. PubMed ID: 34057620
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
[TBL] [Abstract][Full Text] [Related]
15. Rise of the phoenix: Mucormycosis in COVID-19 times.
Ravani SA; Agrawal GA; Leuva PA; Modi PH; Amin KD
Indian J Ophthalmol; 2021 Jun; 69(6):1563-1568. PubMed ID: 34011742
[TBL] [Abstract][Full Text] [Related]
16. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review.
Bhattacharyya A; Sarma P; Sharma DJ; Das KK; Kaur H; Prajapat M; Kumar S; Bansal S; Prakash A; Avti P; Thota P; Reddy DH; Gautam BS; Medhi B
Indian J Pharmacol; 2021; 53(4):317-327. PubMed ID: 34414911
[TBL] [Abstract][Full Text] [Related]
17. COVID Associated Mucormycosis: A Study on the Spectrum of Clinical, Biochemical and Radiological Findings in A Series of Ten Patients.
Pal P; Chatterjee N; Ghosh S; Ray BK; Mukhopadhyay P; Bhunia K; Srivastava SR; Adhikari S; Barman D; Banerjee B; Mukhopadhyay M; Pal J
J Assoc Physicians India; 2021 Oct; 69(10):11-12. PubMed ID: 34781648
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India.
Dravid A; Kashiva R; Khan Z; Bande B; Memon D; Kodre A; Mane M; Pawar V; Patil D; Kalyani S; Raut P; Bapte M; Saldanha C; Chandak D; Patil T; Reddy S; Bhayani K; Suresh L; Dillibabu V; Srivastava S; Khandelwal S; More S; Shakeel A; Pawar M; Nande P; Harshe A; Kadam S; Hallikar S; Kamal N; Andrabi D; Bodhale S; Raut A; Chandrashekhar S; Raman C; Mahajan U; Joshi G; Mane D
Mycoses; 2022 May; 65(5):526-540. PubMed ID: 35212032
[TBL] [Abstract][Full Text] [Related]
19. Long-term Outcome of Coronavirus Disease-associated Mucormycosis: 1-year Follow-up Study from India.
Agrawal P; Singh AP; Chakotiya PS; Kumar V; Gautam A; Kumar D
J Assoc Physicians India; 2024 Jun; 72(6):44-48. PubMed ID: 38881134
[TBL] [Abstract][Full Text] [Related]
20. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B
Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
